Press release
InvivoSciences's CEO Ayla Annac to Present at the 2024 BIO International Convention
The annual BIO International Convention, hosted by the Biotechnology Innovation Organization (BIO), is the world's largest industry gathering. It brings together thousands of global biotechnology and biopharmaceutical leaders over four days and includes networking, programming, and partnering opportunities.
IVS seeks funding to advance its heart failure drug development programs and partnerships to further precision medicine initiatives. Our leading drug candidate in our pipeline, IVS201, discovered through our platform technology Kokordia™, has a well-characterized clinical safety profile and demonstrates anti-fibrotic efficacy through novel mechanisms of action. IVS201 is expected to normalize cardiovascular function in a rare form of heart failure subtype with preserved ejection fraction (HFpEF), identified through our AI-assisted patient stratification technology, which can also be applied to other cardiovascular drug programs.
About InvivoSciences
InvivoSciences (IVS), a Wisconsin-based company, is an IND-enabling-stage biotech company focused on developing therapies for cardiovascular and cardiometabolic diseases. Our Kokordia™ technology platform integrates patient-derived micro heart models (NuHeart™) and AI-assisted clinical trial enrichment diagnostics. Kokordia™ improves the efficacy of clinical trials cost-efficiently by improving the statistical significance with fewer patients, supporting precision medicine in the cardiovascular domain. Our leading drug program in the pipeline, IVS201, targets a specific HFpEF identified through Kokordia™. It addresses interstitial cardiac fibrosis, normalizing diastolic stiffness and hyper-contractility.
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products. Biotechnology industry. Good Day BIO is the only daily newsletter at the intersection of biotech, politics, and policy.
Contact:
Ayla Annac
608 628 8035
aannac@invivosciences.com
About InvivoSciences
InvivoSciences (IVS), a Wisconsin-based company, is an IND-enabling-stage biotech company focused on developing therapies for cardiovascular and cardiometabolic diseases. Our Kokordia™ technology platform integrates patient-derived micro heart models (NuHeart™) and AI-assisted clinical trial enrichment diagnostics. Kokordia™ improves the efficacy of clinical trials cost-efficiently by improving the statistical significance with fewer patients, supporting precision medicine in the cardiovascular domain. Our leading drug program in the pipeline, IVS201, targets a specific HFpEF identified through Kokordia™. It addresses interstitial cardiac fibrosis, normalizing diastolic stiffness and hyper-contractility.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release InvivoSciences's CEO Ayla Annac to Present at the 2024 BIO International Convention here
News-ID: 3501984 • Views: …
More Releases for BIO
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
